<DOC>
	<DOC>NCT02009124</DOC>
	<brief_summary>The purpose of this study is to study the effect of stem cell therapy on common symptoms in patients with spinal cord injury.</brief_summary>
	<brief_title>Stem Cell Therapy in Spinal Cord Injury</brief_title>
	<detailed_description>Autologous bone marrow mononuclear cells are administered intrathecally by a standard procedure followed by vigorous rehabilitation therapy.</detailed_description>
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Diagnosed cases of any type of spinal cord injury age above 12 months. presence of acute infections such as Human immunodeficiency virus/Hepatitis B Virus/Hepatitis C Virus malignancies bleeding tendencies pneumonia renal failure severe liver dysfunction severe anemia [Hemoglobin &lt; 8] any bone marrow disorder space occupying lesion in brain other acute medical conditions such as respiratory infection and pyrexia.</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>spinal cord injury</keyword>
	<keyword>stem cell therapy</keyword>
	<keyword>bone marrow</keyword>
	<keyword>mononuclear cells</keyword>
	<keyword>autologous</keyword>
</DOC>